References:
- Covid19.who.int. 2021. WHO Coronavirus (COVID-19) . [online]
Available at: https://covid19.who.int [Accessed 3 June
2021].
- SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. Late Complications
of COVID-19; a Systematic Review of Current Evidence. Arch Acad Emerg
Med. 2021;9(1):e14. Published 2021 Jan 20. doi:10.22037/aaem.v9i1.1058
- Ghosh K. COVID-19 pneumonia, immunosuppression, and cytomegalovirus
activation: A perspective. Tropical medicine and infectious disease.
2021;67(2):65-6. Editorial commentary.
- CASE IPTA. 237 Coinfection With COVID-19 and Cytomegalovirus in Kidney
Transplant Recipients–A Case Series.
- Iqbal P, Laswi B, Jamshaid MB, Shahzad A, Chaudhry HS, Khan D, et al.
The Role of Anticoagulation in Post-COVID-19 Concomitant Stroke,
Myocardial Infarction, and Left Ventricular Thrombus: A Case Report.
The American journal of case reports. 2021;22:e928852.
- Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus
disease mucormycosis: a deadly addition to the pandemic spectrum. J
Laryngol Otol. 2021;135(5):442-7.
- Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with
COVID-19: a systematic review and meta-analysis. Journal of Infection.
2020;81(2):266-75.
- Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ
transplantation: a review. Infect Chemother. 2013;45(3):260-71.
- Carll WC, Rady MY. Cytomegalovirus haemorrhagic enterocolitis
associated with severe infection with COVID-19. Clinical case reports.
2021;8(1).
- Khatib MY, Shaik KS, Ahmed AA, Alwraidat MA, Mohamed AS.
Tocilizumab-induced cytomegalovirus colitis in a patient with
COVID-19. 2021;9(1):148-52.
- Merchant EA, Flint K, Barouch DH, Blair BM. Co-infection with
coronavirus disease 2019, previously undiagnosed human
immunodeficiency virus, Pneumocystis jirovecii pneumonia and
cytomegalovirus pneumonitis, with possible immune reconstitution
inflammatory syndrome. IDCases. 2021;24:e01153
- Amaral PH, Ferreira BM, Roll S, Neves PD, Pivetta LG, Mohrbacher S, et
al. COVID-19 and Cytomegalovirus Co-infection: A Challenging Case of a
Critically Ill Patient with Gastrointestinal Symptoms. European
journal of case reports in internal medicine. 2020;7(10):001911.
- Carll WC, Rady MY. Cytomegalovirus haemorrhagic enterocolitis
associated with severe infection with COVID-19. Clinical case reports.
2021;8(1).
- D’Ardes D, Boccatonda A, Schiavone C, Santilli F, Guagnano MT, Bucci
M, et al. A case of coinfection with SARS-COV-2 and cytomegalovirus in
the era of COVID-19. European journal of case reports in internal
medicine. 2020;7(5).
- Geisen WR, Berger J, Schwartz C, Reddy A, Rai B, Wadih G, et al.
Cytomegalovirus Enterocolitis secondary to experimental COVID-19
therapy. IDCases. 2020;22:e00962.
- Im JH, Lee J-S, Kwon HY, Chung M-H, Baek J. Epstein–Barr Virus and
Cytomegalovirus Reactivation in Patients with COVID-19. 2020.
- Khatib MY, Shaik KS, Ahmed AA, Alwraidat MA, Mohamed AS.
Tocilizumab-induced cytomegalovirus colitis in a patient with
COVID-19. 2021;9(1):148-52.
- Leemans S, Maillart E, Van Noten H, Oliveira Dos Santos L, Leahu LM,
Kamgang P, et al. Cytomegalovirus haemorrhagic colitis complicating
COVID-19 in an immunocompetent critically ill patient: A case report.
Clinical case reports. 2021;9(5):e03600.
- Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard
A, et al. Cytomegalovirus proctitis as a complication of COVID-19 with
immunosuppressive treatments. IDCases. 2021;24:e01111.
- Oualim S, Elouarradi A, Hafid S, Naitelhou A, Sabry M. A misleading
CMV myocarditis during the COVID-19 pandemic: case report. The Pan
African medical journal. 2020;36:167.
- 3Shah M, Kakar A, Gogia A, Langer S. Convalescent plasma,
cytomegalovirus infection, and persistent leukopenia in COVID-19
recovery phase: What is the link? Journal of postgraduate medicine.
2021;67(2):100-2.
- Simonnet A, Engelmann I, Moreau A-S, Garcia B, Six S, El Kalioubie A,
et al. High incidence of Epstein–Barr virus, cytomegalovirus, and
human-herpes virus-6 reactivations in critically ill patients with
COVID-19. Infectious diseases now. 2021;51(3):296-9.
- Bienvenu A-L, Bleyzac N, Richard J-C, Leboucher G. No time for pending
confirmation of invasive fungal disease in critically ill COVID-19
patients—think empirical treatment. Critical Care. 2020;24(1):588.